← The Wire
VCYTNasdaq
VERACYTE, INC.
Services-Medical Laboratories · DE · CIK 1384101
Develops and distributes in vitro diagnostic tests for global growth
red 8-K · 90d⚡ Elevated coverage
$3.78B
Market cap
$60.19
Last close
-0.5%
1D
+13.2%
5D
1.5M
Volume
Price · last 39 sessions+79.9%
May 4L $32.97 · H $60.49Jun 29
236
Total filings
Jun 11, 2026
Last filing
12/31
Fiscal year end
425425Jun 1, 2021425425Feb 3, 2021425425Feb 3, 2021425425Feb 3, 2021425425Feb 3, 2021425425Feb 3, 2021
Insider Activity
In the 90 days to Mar 4, 2026: 6 sold $5.7M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 4, 2026 | Stapley MarcChief Executive Officer | Sell | 26,279 | $36.28 | $953K |
| Mar 4, 2026 | Stapley MarcChief Executive Officer | Sell | 19,244 | $35.56 | $684K |
| Mar 4, 2026 | Chambers RebeccaChief Financial Officer | Sell | 13,941 | $36.33 | $506K |
| Mar 4, 2026 | Leite JohnChief Commercial Officer-CLIA | Sell | 5,260 | $35.19 | $185K |
| Mar 4, 2026 | Mcguire AnnieSVP, General Counsel | Sell | 4,994 | $35.29 | $176K |
| Mar 4, 2026 | Chambers RebeccaChief Financial Officer | Sell | 4,400 | $35.55 | $156K |
| Mar 4, 2026 | Mcguire AnnieSVP, General Counsel | Sell | 1,664 | $36.34 | $60K |
| Mar 2, 2026 | Febbo Phillip G.Chief Scientific & Med Officer | Sell | 13,425 | $36.16 | $485K |
| Dec 16, 2025 | Mcguire AnnieSVP, General Counsel | Sell | 10,639 | $43.13 | $459K |
| Dec 16, 2025 | Mcguire AnnieSVP, General Counsel | Sell | 100 | $43.68 | $4K |
| Dec 5, 2025 | Eastham KarinDirector | Sell | 12,808 | $45.84 | $587K |
| Dec 5, 2025 | Eastham KarinDirector | Sell | 6,392 | $44.52 | $285K |
| Dec 5, 2025 | Eastham KarinDirector | Sell | 800 | $46.59 | $37K |
| Dec 4, 2025 | Chambers RebeccaChief Financial Officer | Sell | 8,537 | $46.61 | $398K |
| Dec 4, 2025 | Chambers RebeccaChief Financial Officer | Sell | 4,741 | $47.25 | $224K |
| Dec 4, 2025 | Stapley MarcChief Executive Officer | Sell | 4,448 | $46.90 | $209K |
| Dec 4, 2025 | Stapley MarcChief Executive Officer | Sell | 3,220 | $47.35 | $152K |
| Dec 4, 2025 | Leite JohnChief Commercial Officer-CLIA | Sell | 1,278 | $47.51 | $61K |
| Dec 4, 2025 | Mcguire AnnieSVP, General Counsel | Sell | 720 | $47.10 | $34K |
| Dec 4, 2025 | Mcguire AnnieSVP, General Counsel | Sell | 702 | $47.51 | $33K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
In the News
⚡ Elevated coverageCoverage (30d): 2 reputable articles.
Investor's Business DailyStock Market Today: Indexes Mixed Before Warsh’s Fed Debut; Veracyte, Google, Lumentum In Focus13d agoInvestor's Business DailyVeracyte CEO Explains How It's Blazing A Trail In Cancer14d agoReutersVeracyte genomic test identifies breast cancer patients who can skip chemo1mo ago
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance